mRNA |
GDC-0941 |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.06 |
mRNA |
BRD-K99584050 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.06 |
mRNA |
17-AAG |
GDSC1000 |
pan-cancer |
AAC |
0.062 |
0.06 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.063 |
0.06 |
mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
-0.06 |
0.06 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.068 |
0.06 |
mRNA |
Carboplatin |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.06 |
mRNA |
PIK-93 |
CTRPv2 |
pan-cancer |
AAC |
-0.067 |
0.06 |
mRNA |
CH5424802 |
GDSC1000 |
pan-cancer |
AAC |
0.064 |
0.06 |
mRNA |
rigosertib |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.06 |